Direktorat Registrasi ObatValid

MAXIGESIC IV

Claim this product
BPOM Number
DKI2262800149A1
Approved
17 September 2026
Expiry
17 September 2031
Form
CAIRAN UNTUK INFUS

About This Registration

MAXIGESIC IV is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2262800149A1. Its current registration status is Valid, with the licence valid until 17 September 2031. The product is registered to DANKOS FARMA - INDONESIA. BPOM first approved this registration in September 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 18 September 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application
newaero
Packaging
DUS, 10 VIAL @ 100 ML
Department
Direktorat Registrasi Obat
Data Last Updated
18 September 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (4)

IBUPROFEN SODIUM DIHYDRATE<IBUPROFEN SODIUM DIHYDRATE. PARACETAMOLBR>PARACETAMOL

Market Intelligence

Owner Portfolio
DANKOS FARMA - INDONESIA holds 126 BPOM registrations
Manufacturer Scale
DANKOS FARMA - INDONESIA produces 126 registered products
Update Status
Recently updated (5 days ago)

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1